GGrantIndex
Sort

51,593 grants matching hepatitis

Pandemic Infleuenza Virus Vaccines

$3,000,000
Vaxin Inc. · UC1 · FY2005 · AI

Self-Complementary AAV2 Factor IX for Hemophilia B

$2,999,988
Scott William John McPhee · Asklepios Biopharmaceutical, Inc. · RC3 · FY2010 · HL

Regulation of mitochondrial health in mammalian livers.

$2,999,512
Prashant Mishra · Ut Southwestern Medical Center · R01 · FY2025 · DK

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections-A5407 Third Supplement

$2,991,790
Judith S. Currier · University Of California Los Angeles · UM1 · FY2025 · AI

Mechanism and biological consequences of the nuclear receptor CAR activation

$2,990,301
Masahiko Negishi · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES

The Connie Wofsy Women's HIV Study

$2,989,540
Ruth Martha Greenblatt · University Of California, San Francisco · U01 · FY2006 · AI

Characterizing Newly Identified Human Cytomegalovirus Entry Receptors

$2,989,013
David C. Johnson · Oregon Health & Science University · R01 · FY2025 · AI

California Emerging Infections Program

$2,988,222
Arthur L. Reingold · Public Health Foundation Enterprises · U01 · FY2010 · CI

Mechanisms of immune Failure in Chronic Infection: Hepatitis C as a Key Paradigm

$2,987,979
Raymond T Chung · Massachusetts General Hospital · U19 · FY2010 · AI

Multicenter Aids Cohort Study- Part B (Baltimore Site)

$2,984,602
Joseph B. Margolick · Johns Hopkins University · U01 · FY2007 · AI

California Emerging Infections Program

$2,978,843
Arthur L. Reingold · Public Health Foundation Enterprises · U01 · FY2008 · CI

Targeting hepatic stellate cell metabolism to treat steatotic liver disease

$2,978,209
Brian N Finck · Washington University · R01 · FY2025 · DK

Hepatitis B Research Network - Data Coordination Center

$2,972,600
Steven H. Belle · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · DK

IeDEA Asia-Pacific Research Collaboration

$2,971,207
Annette H Sohn · Foundation For Aids Research · U01 · FY2023 · AI

ASSESSMENT OF HEPATITIS C VIRUS (HCV) INFECTION RELATED CHRONIC LIVER DISEASE WITH ADVANCED MULTIPARAMETRIC MAGNETIC RESONANCE ELASTOGRAPHY (MRE)

$2,970,690
Mayo Clinic · · FY2019 · Defense Health Agency

NATURAL HISTORY OF HIV INFECTION IN WOMEN

$2,965,291
Montefiore Medical Center (Bronx, Ny) · U01 · FY2002 · AI

Washington Women's Interagency HIV/AIDS Study

$2,964,133
Seble G Kassaye · Georgetown University · U01 · FY2017 · AI

Mechanisms and biological consequences of the nuclear receptor CAR activation

$2,962,553
Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES

The Connie Wofsy Women's HIV Study

$2,961,505
University Of California San Francisco · U01 · FY2005 · AI

Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments

$2,958,258
Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

SCORE Program at New Mexico State University, Las Cruces

$2,954,691
Glenn D Kuehn · New Mexico State University Las Cruces · S06 · FY2007 · GM

The National Drug Abuse Treatment Clinical Trials Network

$2,953,306
Walter Nmn Ling · University Of California Los Angeles · U10 · FY2015 · DA

Clinical Trials Units for NIAID Networks (UM1)

$2,952,539
Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2014 · AI

Emerging Infections Programs

$2,951,391
Richard Norman Danila · Minnesota State Dept Of Health · U01 · FY2011 · CI

University of Pennsylvania HIV Clinical Trials Unit

$2,946,326
Ian Frank · University Of Pennsylvania · UM1 · FY2024 · AI